Skip to content

A study of the efficacy of online mindfulness therapy in mild to moderate anxiety disorders

A study of the efficacy of online mindfulness therapy in mild to moderate anxiety disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078471
Enrollment
Unknown
Registered
2023-12-08
Start date
2023-12-13
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety disorders

Interventions

Experimental group:Online mindfulness
Control group:treatment as usual

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with an anxiety disorder according to DSM V; 2. Aged >= 18 years; 3. Hamilton Anxiety Scale score 7-23; 4. Familiar with basic mobile phone or computer operation, with network equipment condition required for online intervention; 5. Native Chinese speaker, signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Mental disorders include schizophrenia, bipolar disorder, suicidal major depression, alcohol or other substance abuse; 2. Those who have experience in mindfulness practice; 3. Those who have taken antidepressants, mood stabilizers, antipsychotic drugs, or injected long-acting antipsychotic drugs within two weeks; 4. Patients who are receiving other psychotherapy; 5. Taking drugs that affect heart rate and blood pressure; 6. Serious impairment of vision, hearing, cognitive function, eye diseases; 7. Any condition or impairment that may interfere with the ability to participate in positive pressure decompression; 8. Breastfeeding, pregnancy, or pregnancy plans during the test; 9. Have participated in another clinical trial on mindfulness therapy or a family member has participated in this trial; 10. Reluctance to accept randomization; 11. Serious adverse events or serious deterioration of emotional symptoms occur during the research process, and it is not suitable to continue to participate in the research; 12. Unable to cooperate with the completion of treatment.

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Rating Scale;Hamilton Depression Scale;

Secondary

MeasureTime frame
State-Trait Anxiety Inventory;Holter electrocardiogram;Ambulatory blood pressure monitoring;Eye Exam;electroencephalogram;MRI;

Countries

China

Contacts

Public ContactYang Yuan

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

yuanyang70@hotmail.com+86 139 9556 1816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026